DeWalt, N. C., Yanagihara, T. K., Gallitto, M., Kinslow, C. J., Chiuzan, C., Xu, Y., Singh, G., Bruce, J. N., Wang, T. J. C., & Grinband, J. (2025). Timing of planning MRI and patient selection for adaptive radiotherapy in newly diagnosed high-grade glioma. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.03.037

Saperstein, A. M., Brennan, R., Qian, M., Javitt, D. C., & Medalia, A. (2025). Impact of Early Auditory Processing on Negative Symptom Response to Cognitive Remediation for Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf017

Hoptman, M. J., Girgis, R. R., & Javitt, D. C. (2024). Biomarkers for Cognitive Control, Response Inhibition, Aggressivity, Impulsivity, and Violence. Neurophysiologic Biomarkers in Neuropsychiatric Disorders, 725–756. https://doi.org/10.1007/978-3-031-69491-2_24

Sehatpour, P., & Javitt, D. C. (2024). Advanced Methodology for Neurophysiological Analysis and Biomarker Development: Time–Frequency and Source-Localization Approaches. Neurophysiologic Biomarkers in Neuropsychiatric Disorders, 119–141. https://doi.org/10.1007/978-3-031-69491-2_5

Martínez, A., Hillyard, S. A., & Javitt, D. C. (2024). Visual Neurophysiological Biomarkers for Patient Stratification and Treatment Development Across Neuropsychiatric Disorders. Neurophysiologic Biomarkers in Neuropsychiatric Disorders, 757–799. https://doi.org/10.1007/978-3-031-69491-2_25

Javitt, D. C. (2024). Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia. Neurophysiologic Biomarkers in Neuropsychiatric Disorders, 411–451. https://doi.org/10.1007/978-3-031-69491-2_15

Kantrowitz, J. T., & Javitt, D. C. (2024). The Less Things Change, the More They Remain the Same: Impaired Neural Plasticity as a Critical Target for Drug Development in Neuropsychiatry. Neurophysiologic Biomarkers in Neuropsychiatric Disorders, 801–828. https://doi.org/10.1007/978-3-031-69491-2_26

Petridis, P. D., Grinband, J., Agin-Liebes, G., Kinslow, C. J., Zeifman, R. J., Bogenschutz, M. P., Griffiths, R. R., & Ross, S. (2024). Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer. Nature Mental Health, 2(11), 1408–1414. https://doi.org/10.1038/s44220-024-00331-0

Wang, H., Argenziano, M. G., Yoon, H., Boyett, D., Save, A., Petridis, P., Savage, W., Jackson, P., Hawkins-Daarud, A., Tran, N., Hu, L., Singleton, K. W., Paulson, L., Dalahmah, O. A., Bruce, J. N., Grinband, J., Swanson, K. R., Canoll, P., & Li, J. (2024). Biologically informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post treatment glioblastoma. Npj Digital Medicine, 7(1). https://doi.org/10.1038/s41746-024-01277-4

Sehatpour, P., & Kantrowitz, J. T. (2024). Finding the right dose: NMDAR modulating treatments for cognitive and plasticity deficits in schizophrenia and the role of pharmacodynamic target engagement. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2024.08.019

Sackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., George, M. S., McAlister-Williams, R. H., Prudic, J., Thase, M. E., Young, A. H., & Rush, A. J. (2024). Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2). Journal of Psychiatric Research, 176, 325–337. https://doi.org/10.1016/j.jpsychires.2024.05.046

Laroy, M., Bouckaert, F., Ousdal, O. T., Dols, A., Rhebergen, D., van Exel, E., van Wingen, G., van Waarde, J., Verdijk, J., Kessler, U., Bartsch, H., Jorgensen, M. B., Paulson, O. B., Nordanskog, P., Prudic, J., Sienaert, P., Vandenbulcke, M., Oltedal, L., & Emsell, L. (2024). Characterization of gray matter volume changes from one week to 6 months after termination of electroconvulsive therapy in depressed patients. Brain Stimulation, 17(4), 876–886. https://doi.org/10.1016/j.brs.2024.07.015

Christofalos, A. L., Laks, M., Wolfer, S., Dias, E. C., Javitt, D. C., & Sheridan, H. (2024). Lower-level oculomotor deficits in schizophrenia during multi-line reading: Evidence from return-sweeps. Quarterly Journal of Experimental Psychology, 77(7), 1533–1543. https://doi.org/10.1177/17470218231220752

Naqvi, N. H., Srivastava, A. B., Sanchez‐Peña, J., Lee, J. K., Drysdale, A. T., Mariani, J. J., Ochsner, K. N., Morgenstern, J., Patel, G. H., & Levin, F. R. (2024). Neural correlates of drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder. Alcohol, Clinical and Experimental Research, 48(2), 260–272. Portico. https://doi.org/10.1111/acer.15259

Martínez, A., Gaspar, P. A., Bermudez, D. H., Belen Aburto-Ponce, M., Beggel, O., & Javitt, D. C. (2024). Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing. NeuroImage: Clinical, 41, 103570. https://doi.org/10.1016/j.nicl.2024.103570

Rudchenko, S., Taylor, S., Milosavic, N., Rudchenko, M., Wedderhoff Tissi, B., Mapara, M. Y., & Stojanovic, M. N. (2023). Amplification of Signal on Cell Surfaces in Molecular Cascades. Cells, 12(24), 2858. https://doi.org/10.3390/cells12242858

Nierenberg, A., Lavin, P., Javitt, D. C., Shelton, R., Sapko, M. T., Mathew, S., Besthof, R. E., & Javitt, J. C. (2023). NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial. International Journal of Bipolar Disorders, 11(1). https://doi.org/10.1186/s40345-023-00308-5

Javitt, D. C., Martinez, A., Sehatpour, P., Beloborodova, A., Habeck, C., Gazes, Y., Bermudez, D., Razlighi, Q. R., Devanand, D. P., & Stern, Y. (2023). Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment. Alzheimer’s Research & Therapy, 15(1). https://doi.org/10.1186/s13195-023-01189-7

Sehatpour, P., Kreither, J., Lopez-Calderon, J., Shastry, A. M., De Baun, H. M., Martinez, A., & Javitt, D. C. (2023). Network-level mechanisms underlying effects of transcranial direct current stimulation (tDCS) on visuomotor learning in schizophrenia. Translational Psychiatry, 13(1). https://doi.org/10.1038/s41398-023-02656-3

Tudor, T., Spinazzi, E. F., Alexander, J. E., Mandigo, G. K., Lavine, S. D., Grinband, J., & Connolly, E. S. (2023). Progressive microvascular failure in acute ischemic stroke: A systematic review, meta-analysis, and time-course analysis. Journal of Cerebral Blood Flow & Metabolism, 44(2), 192–208. https://doi.org/10.1177/0271678x231216766

Wen, K., Dai, W., Meng, X., Lin, Q., Wei, J., Tong, L., Taylor, S. K., Rudchenko, S. A., Stojanovic, M. N., Kalantarov, G., & Trakht, I. (2024). Rapid isolation of anti-idiotype aptamers for quantification of human monoclonal antibodies against SARS-CoV-2 spike protein. Biosensors and Bioelectronics, 246, 115842. https://doi.org/10.1016/j.bios.2023.115842

Kinslow, C. J., Rae, A. I., Taparra, K., Kumar, P., Siegelin, M. D., Grinband, J., Gill, B. J. A., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Horowitz, D. P., Kachnic, L. A., Neugut, A. I., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas. Clinical Cancer Research, 29(21), 4399–4407. https://doi.org/10.1158/1078-0432.ccr-23-1295

Sehatpour, P., Iosifescu, D. V., De Baun, H. M., Shope, C., Mayer, M. R., Gangwisch, J., Dias, E., Sobeih, T., Choo, T.-H., Wall, M. M., Medalia, A., Saperstein, A. M., Kegeles, L. S., Girgis, R. R., Carlson, M., & Kantrowitz, J. T. (2023). Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine. Biological Psychiatry, 94(2), 164–173. https://doi.org/10.1016/j.biopsych.2023.01.015

Kinslow, C. J., Mercurio, A., Kumar, P., Rae, A. I., Siegelin, M. D., Grinband, J., Taparra, K., Upadhyayula, P. S., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Kachnic, L. A., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy. JAMA Oncology, 9(7), 919. https://doi.org/10.1001/jamaoncol.2023.0990

Patel, G. H., Gruskin, D. C., Arkin, S. C., Jamerson, E. C., Ruiz-Betancourt, D. R., Klim, C. C., Sanchez-Peña, J. P., Bartel, L. P., Lee, J. K., Grinband, J., Martinez, A., Berman, R. A., Ochsner, K. N., Leopold, D. A., & Javitt, D. C. (2023). The Road Not Taken: Disconnection of a Human-Unique Cortical Pathway Underlying Naturalistic Social Perception in Schizophrenia. Biological Psychiatry Global Open Science, 3(3), 398–408. https://doi.org/10.1016/j.bpsgos.2022.03.008

Kohler, C. G., Wolf, D. H., Abi-Dargham, A., Anticevic, A., Cho, Y. T., Fonteneau, C., Gil, R., Girgis, R. R., Gray, D. L., Grinband, J., Javitch, J. A., Kantrowitz, J. T., Krystal, J. H., Lieberman, J. A., Murray, J. D., Ranganathan, M., Santamauro, N., Van Snellenberg, J. X., Tamayo, Z., … Hohing, T. (2023). Illness Phase as a Key Assessment and Intervention Window for Psychosis. Biological Psychiatry Global Open Science, 3(3), 340–350. https://doi.org/10.1016/j.bpsgos.2022.05.009

Rayman, J. B. (2023). Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies. Expert Opinion on Therapeutic Targets, 27(4–5), 269–279. https://doi.org/10.1080/14728222.2023.2206561

Fertuck, E. A., Stanley, B., Kleshchova, O., Mann, J. J., Hirsch, J., Ochsner, K., Pilkonis, P., Erbe, J., & Grinband, J. (2023). Rejection Distress Suppresses Medial Prefrontal Cortex in Borderline Personality Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 8(6), 651–659. https://doi.org/10.1016/j.bpsc.2022.11.006

Verdolini, N., Moreno-Ortega, M., Salgado-Pineda, P., Monté, G., de Aragón, A. M., Dompablo, M., McKenna, P. J., Salvador, R., Palomo, T., Pomarol-Clotet, E., & Rodriguez-Jimenez, R. (2023). Failure of deactivation in bipolar disorder during performance of an fMRI adapted version of the Stroop task. Journal of Affective Disorders, 329, 307–314. https://doi.org/10.1016/j.jad.2023.02.132

Wen, K., Chen, Y., Meng, X., Botros, S., Dai, W., Stojanovic, M. N., Tomer, R., & Lin, Q. (2023). A microfluidic dual-aptamer sandwich assay for rapid and cost-effective detection of recombinant proteins. Microchemical Journal, 188, 108454. https://doi.org/10.1016/j.microc.2023.108454

Dondé, C., Kantrowitz, J. T., Medalia, A., Saperstein, A. M., Balla, A., Sehatpour, P., Martinez, A., O’Connell, M. N., & Javitt, D. C. (2023). Early auditory processing dysfunction in schizophrenia: Mechanisms and implications. Neuroscience & Biobehavioral Reviews, 148, 105098. https://doi.org/10.1016/j.neubiorev.2023.105098

Medalia, A., Saperstein, A., Javitt, D. C., Qian, M., Meyler, S., & Styke, S. (2023). Feasibility and clinical utility of using the tone matching test for assessment of early auditory processing in schizophrenia. Psychiatry Research, 323, 115152. https://doi.org/10.1016/j.psychres.2023.115152

Javitt, D. C. (2023). Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annual Review of Pharmacology and Toxicology, 63(1), 119–141. https://doi.org/10.1146/annurev-pharmtox-051921-093250

Taylor, S. K., Kostic, N., & Stojanovic, M. N. (2022). Oligonucleotide-Blocked Streptavidin for Biotinylation Analysis. Bioconjugate Chemistry, 34(1), 92–96. https://doi.org/10.1021/acs.bioconjchem.2c00255

Svensson, S. F., Halldórsson, S., Latysheva, A., Fuster-Garcia, E., Hjørnevik, T., Fraser-Green, J., Birkeland Bugge, R. A., Grinband, J., Holm, S., Sinkus, R., Vik-Mo, E. O., & Emblem, K. E. (2023). MR elastography identifies regions of extracellular matrix reorganization associated with shorter survival in glioblastoma patients. Neuro-Oncology Advances, 5(1). https://doi.org/10.1093/noajnl/vdad021

Wang, X., Chang, S., Grinband, J., Yannuzzi, L. A., Freund, K. B., Hoang, Q. V., & Girard, M. J. (2021). Optic nerve tortuosity and displacements during horizontal eye movements in healthy and highly myopic subjects. British Journal of Ophthalmology, 106(11), 1596–1602. https://doi.org/10.1136/bjophthalmol-2021-318968

Spinazzi, E. F., Argenziano, M. G., Upadhyayula, P. S., Banu, M. A., Neira, J. A., Higgins, D. M. O., Wu, P. B., Pereira, B., Mahajan, A., Humala, N., Al-Dalahmah, O., Zhao, W., Save, A. V., Gill, B. J. A., Boyett, D. M., Marie, T., Furnari, J. L., Sudhakar, T. D., Stopka, S. A., … Bruce, J. N. (2022). Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial. The Lancet Oncology, 23(11), 1409–1418. https://doi.org/10.1016/s1470-2045(22)00599-x

Qian, N., Lipkin, R. M., Kaszowska, A., Silipo, G., Dias, E. C., Butler, P. D., & Javitt, D. C. (2022). Computational modeling of excitatory/inhibitory balance impairments in schizophrenia. Schizophrenia Research, 249, 47–55. https://doi.org/10.1016/j.schres.2020.03.027

Drysdale, A. T., & Patel, G. H. (2022). A Dynamic Approach to Depression Treatment Prediction. Biological Psychiatry, 92(7), 526–527. https://doi.org/10.1016/j.biopsych.2022.06.028

Gruskin, D. C., & Patel, G. H. (2022). Brain connectivity at rest predicts individual differences in normative activity during movie watching. NeuroImage, 253, 119100. https://doi.org/10.1016/j.neuroimage.2022.119100

Murithi, J. M., Deni, I., Pasaje, C. F. A., Okombo, J., Bridgford, J. L., Gnädig, N. F., Edwards, R. L., Yeo, T., Mok, S., Burkhard, A. Y., Coburn-Flynn, O., Istvan, E. S., Sakata-Kato, T., Gomez-Lorenzo, M. G., Cowell, A. N., Wicht, K. J., Le Manach, C., Kalantarov, G. F., Dey, S., … Fidock, D. A. (2022). The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance. Cell Chemical Biology, 29(5), 824-839.e6. https://doi.org/10.1016/j.chembiol.2021.06.006

Javitt, D. C., & Kantrowitz, J. T. (2022). The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease. Schizophrenia Research, 242, 56–61. https://doi.org/10.1016/j.schres.2022.01.013

Martínez, A., Tobe, R. H., Gaspar, P. A., Malinsky, D., Dias, E. C., Sehatpour, P., Lakatos, P., Patel, G. H., Bermudez, D. H., Silipo, G., & Javitt, D. C. (2022). Disease-Specific Contribution of Pulvinar Dysfunction to Impaired Emotion Recognition in Schizophrenia. Frontiers in Behavioral Neuroscience, 15. https://doi.org/10.3389/fnbeh.2021.787383

Hoptman, M. J., Tural, U., Lim, K. O., Javitt, D. C., & Oberlin, L. E. (2022). Relationships between Diffusion Tensor Imaging and Resting State Functional Connectivity in Patients with Schizophrenia and Healthy Controls: A Preliminary Study. Brain Sciences, 12(2), 156. https://doi.org/10.3390/brainsci12020156

Sehatpour, P., Javitt, D. C., De Baun, H. M., Carlson, M., Beloborodova, A., Margolin, D. H., Carlton, M. B. L., Brice, N. L., & Kantrowitz, J. T. (2021). Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058. Neuropsychopharmacology, 47(3), 711–718. https://doi.org/10.1038/s41386-021-01170-8

Park, J., Yang, K.-A., Choi, Y., & Choe, J. K. (2022). Novel ssDNA aptamer-based fluorescence sensor for perfluorooctanoic acid detection in water. Environment International, 158, 107000. https://doi.org/10.1016/j.envint.2021.107000

Wang, B., Zhao, C., Wang, Z., Yang, K.-A., Cheng, X., Liu, W., Yu, W., Lin, S., Zhao, Y., Cheung, K. M., Lin, H., Hojaiji, H., Weiss, P. S., Stojanović, M. N., Tomiyama, A. J., Andrews, A. M., & Emaminejad, S. (2022). Wearable aptamer-field-effect transistor sensing system for noninvasive cortisol monitoring. Science Advances, 8(1). https://doi.org/10.1126/sciadv.abk0967

Lisanby, S. H., McClintock, S. M., McCall, W. V., Knapp, R. G., Cullum, C. M., Mueller, M., Deng, Z.-D., Teklehaimanot, A. A., Rudorfer, M. V., Bernhardt, E., Alexopoulos, G., Bailine, S. H., Briggs, M. C., Geduldig, E. T., Greenberg, R. M., Husain, M. M., Kaliora, S., Latoussakis, V., Liebman, L. S., … Kellner, C. H. (2022). Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study. The American Journal of Geriatric Psychiatry, 30(1), 15–28. https://doi.org/10.1016/j.jagp.2021.04.006

Petridis, P. D., Horenstein, C. I., Pereira, B., Wu, P. B., Samanamud, J., Marie, T., Boyett, D., Sudhakar, T. D., Sheth, S. A., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P., & Grinband, J. (2021). BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas. Neuro-Oncology, 24(1), 78–87. https://doi.org/10.1093/neuonc/noab154

Patel, G. H., Arkin, S. C., Ruiz-Betancourt, D. R., DeBaun, H. M., Strauss, N. E., Bartel, L. P., Grinband, J., Martinez, A., Berman, R. A., Leopold, D. A., & Javitt, D. C. (2020). What you see is what you get: visual scanning failures of naturalistic social scenes in schizophrenia. Psychological Medicine, 51(16), 2923–2932. https://doi.org/10.1017/s0033291720001646